Thiazide diuretics and fractures: can meta-analysis help?

Area of Science:

• Pharmacology and Geriatric Medicine
• Epidemiology of Bone Diseases

Background:

• Observational studies show conflicting results on thiazide diuretics' effect on osteoporotic fracture risk, ranging from significant reduction to increase.
• No randomized controlled trials (RCTs) have been conducted to definitively assess this relationship.

Purpose of the Study:

• To resolve conflicting observational data on thiazide diuretics and osteoporotic fracture risk using meta-analysis.
• To investigate the influence of therapy duration and/or dose on fracture risk associated with thiazide use.

Main Methods:

• Systematic search of Medline and Excerpta Medica databases, supplemented by reviews and reference checking.
• Meta-analysis of 13 observational studies involving 29,600 subjects with extractable data on thiazides and fracture occurrence.

Main Results:

• Current thiazide users demonstrated protection against hip fracture (OR 0.82, 95% CI 0.73-0.91).
• Long-duration thiazide use suggested protection (OR 0.82, 95% CI 0.62-1.08), while short-duration use did not show a significant protective effect (OR 1.23, 95% CI 0.99-1.54).
• Overall, current thiazide users showed a 20% reduction in fracture risk, with long-term use potentially offering similar or greater benefit.

Conclusions:

• Current thiazide use is associated with a reduced risk of osteoporotic fractures.
• Long-term thiazide therapy may offer a protective effect against fractures, comparable to other established interventions.
• The study highlights the need for an RCT, but acknowledges the significant logistical challenges for high-risk populations.